Clinical Trial Update: To Evaluate the Efficacy and Safety in Patients With Dyslipidemia and Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and safety of a drug in patients with dyslipidemia and hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypertension

Snippet

Sponsor: JW Pharmaceutical | Conditions: Dyslipidemia, Hypertension | Phase 3 | Status: COMPLETED